Your browser doesn't support javascript.
loading
Blockade of a Laminin-411-Notch Axis with CRISPR/Cas9 or a Nanobioconjugate Inhibits Glioblastoma Growth through Tumor-Microenvironment Cross-talk.
Sun, Tao; Patil, Rameshwar; Galstyan, Anna; Klymyshyn, Dmytro; Ding, Hui; Chesnokova, Alexandra; Cavenee, Webster K; Furnari, Frank B; Ljubimov, Vladimir A; Shatalova, Ekaterina S; Wagner, Shawn; Li, Debiao; Mamelak, Adam N; Bannykh, Serguei I; Patil, Chirag G; Rudnick, Jeremy D; Hu, Jethro; Grodzinski, Zachary B; Rekechenetskiy, Arthur; Falahatian, Vida; Lyubimov, Alexander V; Chen, Yongmei L; Leoh, Lai S; Daniels-Wells, Tracy R; Penichet, Manuel L; Holler, Eggehard; Ljubimov, Alexander V; Black, Keith L; Ljubimova, Julia Y.
Afiliación
  • Sun T; Nanomedicine Research Center, Department of Neurosurgery, Cedars-Sinai Medical Center, Los Angeles, California.
  • Patil R; Nanomedicine Research Center, Department of Neurosurgery, Cedars-Sinai Medical Center, Los Angeles, California.
  • Galstyan A; Samuel Oschin Comprehensive Cancer Center, Cedars-Sinai Medical Center, Los Angeles, California.
  • Klymyshyn D; Nanomedicine Research Center, Department of Neurosurgery, Cedars-Sinai Medical Center, Los Angeles, California.
  • Ding H; Nanomedicine Research Center, Department of Neurosurgery, Cedars-Sinai Medical Center, Los Angeles, California.
  • Chesnokova A; Nanomedicine Research Center, Department of Neurosurgery, Cedars-Sinai Medical Center, Los Angeles, California.
  • Cavenee WK; Samuel Oschin Comprehensive Cancer Center, Cedars-Sinai Medical Center, Los Angeles, California.
  • Furnari FB; Nanomedicine Research Center, Department of Neurosurgery, Cedars-Sinai Medical Center, Los Angeles, California.
  • Ljubimov VA; Ludwig Institute for Cancer Research, University of California San Diego, La Jolla, California.
  • Shatalova ES; Ludwig Institute for Cancer Research, University of California San Diego, La Jolla, California.
  • Wagner S; Department of Neurosurgery, Cedars-Sinai Medical Center, Los Angeles, California.
  • Li D; Nanomedicine Research Center, Department of Neurosurgery, Cedars-Sinai Medical Center, Los Angeles, California.
  • Mamelak AN; Biomedical Imaging Research Institute, Cedars-Sinai Medical Center, Los Angeles, California.
  • Bannykh SI; Biomedical Imaging Research Institute, Cedars-Sinai Medical Center, Los Angeles, California.
  • Patil CG; Samuel Oschin Comprehensive Cancer Center, Cedars-Sinai Medical Center, Los Angeles, California.
  • Rudnick JD; Department of Neurosurgery, Cedars-Sinai Medical Center, Los Angeles, California.
  • Hu J; Samuel Oschin Comprehensive Cancer Center, Cedars-Sinai Medical Center, Los Angeles, California.
  • Grodzinski ZB; Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, California.
  • Rekechenetskiy A; Department of Neurosurgery, Cedars-Sinai Medical Center, Los Angeles, California.
  • Falahatian V; Samuel Oschin Comprehensive Cancer Center, Cedars-Sinai Medical Center, Los Angeles, California.
  • Lyubimov AV; Department of Neurosurgery, Cedars-Sinai Medical Center, Los Angeles, California.
  • Chen YL; Samuel Oschin Comprehensive Cancer Center, Cedars-Sinai Medical Center, Los Angeles, California.
  • Leoh LS; Department of Neurosurgery, Cedars-Sinai Medical Center, Los Angeles, California.
  • Daniels-Wells TR; Nanomedicine Research Center, Department of Neurosurgery, Cedars-Sinai Medical Center, Los Angeles, California.
  • Penichet ML; St. George's University c/o University Support Services, LLC, Great River, New York.
  • Holler E; Duke University School of Medicine, Department of Biostatistics and Bioinformatics, Clinical Research Training Program (CRTP), Durham, North Carolina.
  • Ljubimov AV; Toxicology Research Laboratory (TRL), Department of Pharmacology, University of Illinois at Chicago, Chicago, Illinois.
  • Black KL; Toxicology Research Laboratory (TRL), Department of Pharmacology, University of Illinois at Chicago, Chicago, Illinois.
  • Ljubimova JY; Division of Surgical Oncology, Department of Surgery, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California.
Cancer Res ; 79(6): 1239-1251, 2019 03 15.
Article en En | MEDLINE | ID: mdl-30659021
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Células Madre Neoplásicas / Laminina / Glioblastoma / Receptores Notch / Nanopartículas / Microambiente Tumoral / Sistemas CRISPR-Cas Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Cancer Res Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Células Madre Neoplásicas / Laminina / Glioblastoma / Receptores Notch / Nanopartículas / Microambiente Tumoral / Sistemas CRISPR-Cas Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Cancer Res Año: 2019 Tipo del documento: Article